Multiple functional in vitro assays, including analysis of NK cell activation, degranulation, cytokine release as well cytotoxicity revealed that B7-H3-SDIE is well suited to target pancreatic cancer cells because it potently induced anti-tumor immunity. This evidence concerns the gene CD276 and familial pancreatic carcinoma.